Skip to content

Batch information on every product pageTHC < 0.3%Shipped from France10% off when you sign up

PF-622

Piperazine urea that inhibits FAAH by covalent modification of the active-site serine, completely selective among the mammalian serine hydrolases tested.

Level of detail

Harm-reduction warning

No characterised human dose: animal / in vitro data only. Effect profile, safety margin and acute toxicity are not documented in human clinical practice. Extremely potent compound: severe effects, seizures and deaths reported in the literature.

C₂₁H₂₂N₄O

CID 11515763

Family
ECS pharmacological toolEnzyme inhibitor
Molar mass
346.40 g/mol

Updated on

In plain terms

PF-622 blocks the enzyme that destroys anandamide, one of the cannabinoids the body makes. Its interest is being very precise: in the tests, it touches no other enzyme of the same type. It has remained a laboratory tool; no study in humans was found.

Receptors and activity

Target network

FAAHInhibitorTime-dependent covalent inhibition (modification of the active-site nucleophilic serine); complete selectivity among mammalian serine hydrolases in activity-based probe profiling; no numerical value in the abstract of Ahn et al. 2007; other publications: IC50 of 19 to 991 nM depending on the assay (ChEMBL)
  • Blocks or inhibits

The lower the cited value, the closer the target sits to PF-622: one ring per factor of 100. A target with no measured value stays on the edge.

Where these targets live

Where each target has been found in humans, according to the cited studies. The map shows the target, not an effect of PF-622.

Brain, side view
Body, front view
Blood

FAAHFAAH found in 7 regions of the body

  1. CortexpresentCortical pyramidal neurons1
  2. Basal gangliapresentStriatal neurons1
  3. HypothalamuspresentPresent in hypothalamic nuclei1
  4. CerebellumpresentPurkinje cells and cerebellar layers1
  5. BrainstempresentInferior olivary nuclei1
  6. Adipose tissuepresentExpressed in mature adipocytes2
  7. BonepresentPresent on osteoclasts3

Cited values

  1. FAAHInhibitorno measured value cited

    Time-dependent covalent inhibition (modification of the active-site nucleophilic serine); complete selectivity among mammalian serine hydrolases in activity-based probe profiling; no numerical value in the abstract of Ahn et al. 2007; other publications: IC50 of 19 to 991 nM depending on the assay (ChEMBL)

Bar length follows the measured value (Ki, Kd, EC50 or IC50), on one scale shared by every entry, from 100 µM to 0.1 nM. A target with no cited value has no bar.

Pharmacology

PF-622 was published in 2007 with PF-750 as the lead of a new mechanistic class of FAAH inhibitors. The paper by Ahn and colleagues describes piperidine and piperazine ureas that are more potent in vitro than earlier classes, and whose inhibition of FAAH, unexpectedly given the chemical stability of the urea group, is time-dependent and goes through covalent modification of the active-site serine nucleophile. Activity-based proteomic profiling shows them to be completely selective for FAAH among other mammalian serine hydrolases, a specificity the authors link to FAAH's special ability to hydrolyse C(O)-N bonds, where most serine hydrolases cut only esters or thioesters. The authors see in them a privileged scaffold for FAAH inhibitors combining potency and selectivity. For class context, a phase 1 study of another FAAH inhibitor, BIA 10-2474, led to the death of one volunteer and neurological symptoms in four others; the cause is unknown and a hypothesis of inhibition of several lipases not targeted by a highly selective FAAH inhibitor has been put forward (van Esbroeck et al. 2017). No study in whole animals or in humans was found for PF-622.

History

Source
An entirely synthetic compound with no natural occurrence. It is known as a pharmacology reagent, a demonstration tool for a new mechanistic class; no clinical development was found in the sources consulted.

Origin

Research tool

No biological pathway: PF-622 is a synthetic compound of the piperazine urea class, unrelated to the plant cannabinoid pathway.

Classification

Family, origin and source verification

Family

ECS pharmacological tool › Enzyme inhibitor

Verification

Classification, sources and binding values checked on 20 October 2026; text read against its sources and Wikipedia.

Wikipedia (English)

No dedicated article.

References

Identifiers

Names

IUPAC name
N-phenyl-4-(quinolin-2-ylmethyl)piperazine-1-carboxamide
Other names
PF 622 · PF622

Identifiers

Formula
C₂₁H₂₂N₄O
InChIKey
SNTCRRMCALVGNL-UHFFFAOYSA-N
SMILES
C1CN(CCN1CC2=NC3=CC=CC=C3C=C2)C(=O)NC4=CC=CC=C4

Machine-readable entry (JSON)

LLM ingestion format: a structured superset of the entry (identifiers, binding, versioned legal status). Full corpus.